Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor

Background: Neoplasms in the head and neck region possess higher glycolytic activity than normal tissue, showing increased glucose metabolism. F-18-Flourodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can identify an unknown primary tumor (CUP). Aim: The aim of this stu...

Full description

Bibliographic Details
Main Authors: Friederike Eilsberger, Friederike Elisabeth Noltenius, Damiano Librizzi, Joel Wessendorf, Markus Luster, Stephan Hoch, Andreas Pfestroff
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/9/2095
_version_ 1797490955920605184
author Friederike Eilsberger
Friederike Elisabeth Noltenius
Damiano Librizzi
Joel Wessendorf
Markus Luster
Stephan Hoch
Andreas Pfestroff
author_facet Friederike Eilsberger
Friederike Elisabeth Noltenius
Damiano Librizzi
Joel Wessendorf
Markus Luster
Stephan Hoch
Andreas Pfestroff
author_sort Friederike Eilsberger
collection DOAJ
description Background: Neoplasms in the head and neck region possess higher glycolytic activity than normal tissue, showing increased glucose metabolism. F-18-Flourodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can identify an unknown primary tumor (CUP). Aim: The aim of this study was to assess the real-life performance of F-18-FDG-PET/CT in detecting primary sites in patients with cervical lymph node metastasis of CUP. Methods: A retrospective data analysis of 31 patients who received FDG-PET/CT between June 2009 and March 2015 in a CUP context with histologically confirmed cervical lymph node metastasis was included. Results: In 48% of the patients (15/31), PET/CT showed suspicious tracer accumulation. In 52% of the patients (16/31), there was no suspicious radiotracer uptake, which was confirmed by the lack of identification of any primary tumor in 10 cases until the end of follow-up. FDG-PET/CT had a sensitivity of 67%, specificity of 91%, PPV of 92%, and NPV of 63% in detecting the primary tumor. Additionally, PET/CT showed suspicious tracer accumulation according to further metastasis in 32% of the patients (10/31). Conclusion: FDG-PET/CT imaging is a useful technique for primary tumor detection in patients in a cervical CUP context. Furthermore, it provides information on the ulterior metastasis of the disease.
first_indexed 2024-03-10T00:40:29Z
format Article
id doaj.art-93a45535e5d3476490d13b26c2b94d66
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T00:40:29Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-93a45535e5d3476490d13b26c2b94d662023-11-23T15:09:05ZengMDPI AGBiomedicines2227-90592022-08-01109209510.3390/biomedicines10092095Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary TumorFriederike Eilsberger0Friederike Elisabeth Noltenius1Damiano Librizzi2Joel Wessendorf3Markus Luster4Stephan Hoch5Andreas Pfestroff6Department of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Otolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, GermanyBackground: Neoplasms in the head and neck region possess higher glycolytic activity than normal tissue, showing increased glucose metabolism. F-18-Flourodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can identify an unknown primary tumor (CUP). Aim: The aim of this study was to assess the real-life performance of F-18-FDG-PET/CT in detecting primary sites in patients with cervical lymph node metastasis of CUP. Methods: A retrospective data analysis of 31 patients who received FDG-PET/CT between June 2009 and March 2015 in a CUP context with histologically confirmed cervical lymph node metastasis was included. Results: In 48% of the patients (15/31), PET/CT showed suspicious tracer accumulation. In 52% of the patients (16/31), there was no suspicious radiotracer uptake, which was confirmed by the lack of identification of any primary tumor in 10 cases until the end of follow-up. FDG-PET/CT had a sensitivity of 67%, specificity of 91%, PPV of 92%, and NPV of 63% in detecting the primary tumor. Additionally, PET/CT showed suspicious tracer accumulation according to further metastasis in 32% of the patients (10/31). Conclusion: FDG-PET/CT imaging is a useful technique for primary tumor detection in patients in a cervical CUP context. Furthermore, it provides information on the ulterior metastasis of the disease.https://www.mdpi.com/2227-9059/10/9/2095FDG-PET/CTunknown primary tumorCUPlymph node metastasis
spellingShingle Friederike Eilsberger
Friederike Elisabeth Noltenius
Damiano Librizzi
Joel Wessendorf
Markus Luster
Stephan Hoch
Andreas Pfestroff
Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
Biomedicines
FDG-PET/CT
unknown primary tumor
CUP
lymph node metastasis
title Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
title_full Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
title_fullStr Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
title_full_unstemmed Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
title_short Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
title_sort real life performance of f 18 fdg pet ct in patients with cervical lymph node metastasis of unknown primary tumor
topic FDG-PET/CT
unknown primary tumor
CUP
lymph node metastasis
url https://www.mdpi.com/2227-9059/10/9/2095
work_keys_str_mv AT friederikeeilsberger reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT friederikeelisabethnoltenius reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT damianolibrizzi reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT joelwessendorf reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT markusluster reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT stephanhoch reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor
AT andreaspfestroff reallifeperformanceoff18fdgpetctinpatientswithcervicallymphnodemetastasisofunknownprimarytumor